These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1465814)

  • 1. Living-unrelated renal transplantation.
    Simforoosh N; Bassiri A; Amiransari B; Gol S
    Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
    [No Abstract]   [Full Text] [Related]  

  • 2. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine-related hypercoagulability: fact or fiction?
    Edwards CM; Morgan JD; Donnelly PK
    Transplant Proc; 1992 Dec; 24(6):2616-7. PubMed ID: 1465885
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
    Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
    Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z; Adam K; Parapanissiou E; Sakellariou G; Papakyriazi E; Antoniadis A; Papadimitriou M
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract]   [Full Text] [Related]  

  • 9. Postoperative endogenous serum cortisol level as indicator of the immunosuppressive efficacy of prednisolone in kidney allograft recipients.
    Kaden J; Egerer K; May G; Schreiner S; Wesslau C; Schönemann C; Egerer B
    Transplant Proc; 1992 Dec; 24(6):2622-3. PubMed ID: 1465888
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract]   [Full Text] [Related]  

  • 11. DR6 compatibility and kidney graft survival.
    Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K; Kim YS; Kim SI
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract]   [Full Text] [Related]  

  • 13. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney transplantation in Slovenia from 1986 through 1991.
    Kandus A; Buturović-Ponikvar J; Malovrh M; Bren AF
    Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose OKT3 for cadaveric renal transplantation.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
    [No Abstract]   [Full Text] [Related]  

  • 16. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
    Christiaans MH; van den Berg-Loonen PM; Nieman FH; van Hooff JP
    Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
    [No Abstract]   [Full Text] [Related]  

  • 17. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract]   [Full Text] [Related]  

  • 18. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation.
    Berthoux FC; Guerin C; Burgard G; Berthoux P; Alamartine E
    Transplant Proc; 1992 Dec; 24(6):2578-82. PubMed ID: 1465872
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.